Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Neuroendocrine Immunoregulation in Multiple Sclerosis.
Small Molecules in Stem Cell Research.
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS.
Multiple sclerosis.
Multiple sclerosis, solitary sclerosis or something else?
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Substance Name: Phenytoin
Fingolimod (Gilenya) licence extended
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
[Sociological research in Samara Oblast: a role of social organizations of patients in the improvement of quality of medical and social care].
A nurse-led mental health service for people with multiple sclerosis.
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.
Venocentric Lesions: An MRI Marker of MS?
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.
Non-local robust detection of DTI white matter differences with small databases.
Nrf2 in health and disease: current and future clinical implications.
Pages
« first
‹ previous
…
219
220
221
222
223
224
225
226
227
…
next ›
last »